Unknown

Dataset Information

0

SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation.


ABSTRACT: To characterize the mechanisms that govern chemoresistance, we performed a comparative proteomic study analyzing head and neck squamous cell carcinoma (HNSCC) cells: CCL-138 (parental), CCL-138-R (cisplatin-resistant), and cancer stem cells (CSCs). Syntenin-1 (SDCBP) was upregulated in CCL-138-R cells and CSCs over parental cells. SDCBP depletion sensitized biopsy-derived and established HNSCC cell lines to cisplatin (CDDP) and reduced CSC markers, Src activation being the main SDCBP downstream target. In mice, SDCBP-depleted cells formed tumors with decreased mitosis, Ki-67 positivity, and metastasis over controls. Moreover, the fusocellular pattern of CCL-138-R cell-derived tumors reverted to a more epithelial morphology upon SDCBP silencing. Importantly, SDCBP expression was associated with Src activation, poor differentiated tumor grade, advanced tumor stage, and shorter survival rates in a series of 382 HNSCC patients. Our results reveal that SDCBP might be a promising therapeutic target for effectively eliminating CSCs and CDDP resistance.

SUBMITTER: Mir C 

PROVIDER: S-EPMC8508472 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7020369 | biostudies-literature
| S-EPMC7806466 | biostudies-literature
| S-EPMC6689034 | biostudies-literature
| S-EPMC7694336 | biostudies-literature
| S-EPMC11005150 | biostudies-literature
2022-03-01 | PXD001438 | Pride
| S-EPMC9675605 | biostudies-literature
| S-EPMC7054324 | biostudies-literature
| S-EPMC7944998 | biostudies-literature
| S-EPMC8226229 | biostudies-literature